Terkko Navigator / -/ Feeds / " ( ( Biologiset merkkiaineet )|( Biologinen merkkiaine )|( Biologinen ilmaisin )|( Merkkia"

Cancers, Vol. 14, Pages 2571: Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping

Cancers, Vol. 14, Pages 2536: Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy

Cancers, Vol. 14, Pages 2539: Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Cancers, Vol. 14, Pages 2429: Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer

Cancers, Vol. 14, Pages 2531: Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

Cancers, Vol. 14, Pages 2490: Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells

Cancers, Vol. 13, Pages 4871: Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors

Cancers, Vol. 14, Pages 1054: The New Era of Immunotherapy in Gastric Cancer

Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML

Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival

Cancers, Vol. 14, Pages 2408: Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments

Cancers, Vol. 14, Pages 2457: Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors

Cancers, Vol. 14, Pages 2502: Characterization of Poorly Cohesive and Signet Ring Cell Carcinomas and Identification of PTPRM as a Diagnostic Marker

Cancers, Vol. 14, Pages 2514: Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.

Cancers, Vol. 13, Pages 395: Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment

Cancers, Vol. 13, Pages 2550: MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells

Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: interim analysis of phase III clinical study

ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.

IJMS, Vol. 21, Pages 6386: Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers (EGTM) 2013 guidelines update.

Cancers, Vol. 12, Pages 2519: Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

Cancers, Vol. 12, Pages 2519: Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

Cancers, Vol. 13, Pages 231: Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

Cancers, Vol. 13, Pages 231: Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

Cancers, Vol. 13, Pages 5661: Pimavanserin: A Novel Autophagy Modulator for Pancreatic Cancer Treatment

Cancers, Vol. 13, Pages 6016: Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach

Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.

Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.

Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.

Cancers, Vol. 12, Pages 2428: Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer

Cancers, Vol. 12, Pages 2428: Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer

Biomarkers of progression to oral cancer in patients with dysplasia: A systematic review.

Cancers, Vol. 12, Pages 3389: Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity